Value Through Innovation21 November 2014

Advancement in Equine Research Award

At Boehringer Ingelheim Vetmedica, Inc., we're furthering our commitment to research efforts to ensure that we continue to learn more about equine diseases.

Scientists, researchers, practicing veterinarians, animal health companies and horse owners have long been dedicated to improving the health of the horse. Yet the need for more knowledge in regards to disease prevention, lameness and general wellness still exists.

At Boehringer Ingelheim Vetmedica, Inc., we're furthering our commitment to research efforts to ensure that we continue to learn more about equine diseases.

We are pleased to announce the third annual Boehringer Ingelheim Advancement in Equine Research Award Program. The deadline for submissions is September 15, 2014.

The 2014 Advancement in Equine Research Award recipients will be announced at the American Association of Equine Practitioners Conference in Salt Lake City, Utah.

The BIVI Equine Research Award will focus on one specific equine disease area each year. For 2014, the equine disease of focus is equine infectious disease. 

Proposals must address one or more specific criteria to be considered:

  • Practical application and ability to improve the diagnosis, pathogenesis, transmission, control and/or prevention of equine infectious disease(s)
  • Disease(s) can be bacterial or viral etiologies

Boehringer Ingelheim will provide five $15,000 awards to the winning proposals for equine infectious disease research. Veterinarians, diagnosticians, public and private researchers in the United States and Canada are eligible to submit proposals for research programs that help advance the diagnosis, treatment and understanding of equine infectious disease(s). Winning proposals will be selected by an independent review board.

Our independent Equine Research Review Board members look forward to reviewing your proposals.

Proposals Due 

The deadline for proposals for the 2014Advancement in Equine Research Award is: September 15, 2014

Submit Your Proposal To:

  • The 2014 Advancement in Equine Research Award

    Boehringer Ingelheim Vetmedica, Inc.
    Attn: Dr. Steve Grubbs
    3902 Gene Field Road
    St. Joseph, Missouri 64506

    Mark the envelope “The Advancement in Equine Research Award”


About Boehringer Ingelheim Vetmedica

Boehringer Ingelheim Vetmedica, Inc., (BIVI) is a leader in the animal health industry with its portfolio of innovative vaccine and pharmaceutical solutions for the prevention and treatment of disease within the swine, cattle, equine and pet markets. BIVI is the U.S. division of the global Boehringer Ingelheim Animal Health GmbH. Our U.S. headquarters are located within the KC Animal Health Corridor in St. Joseph, Mo., with other sites in Ames, Fort Dodge and Sioux Center, Iowa.

The Boehringer Ingelheim group is one of the world’s 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 142 affiliates and more than 47,400 employees. Since it was founded in 1885, the family-owned company has been committed to researching, developing, manufacturing and marketing new medications of high therapeutic value for human and veterinary medicine.

Social responsibility is a central element of Boehringer Ingelheim’s culture. Involvement in social projects, caring for the employees and their families and providing equal opportunities for all employees form the foundation of the global operations. Mutual cooperation and respect, as well as environmental protection and sustainability are intrinsic factors of all Boehringer Ingelheim’s endeavors.

With nearly 3,000 employees worldwide, Boehringer Ingelheim Animal Health achieved net sales of about $1.46 billion (1.07 billion euros) in 2013. In our research-driven Animal Health business, Boehringer Ingelheim continually invests more than 10% of net sales of the Animal Health business in R&D.

Contact Us

  • The Advancement in Equine Research Award

    Boehringer Ingelheim Vetmedica, Inc.
    Attn: Dr. Steve Grubbs
    3902 Gene Field Road
    St. Joseph, Missouri 64506